Enabling Clinical Genomics with Highly Multiplexed and Patient-like Reference Materials
March 1, 2017 - Toronto ON CAXtalks Life Science Webinars
helpdesk@xtalks.com
Phone:416 977 6555 ex 371
Next generation sequencing (NGS) based clinical genomics assays are increasingly being offered by laboratories worldwide across a wide range of disease areas, including cancer, reproductive health, inherited disease and infectious disease. Developing, optimizing, and monitoring such assays however can be a time consuming and challenging task. Scientists and clinicians can build and implement robust and accurate clinical genomics assays with the help of highly multiplexed and patient-like reference materials. These innovative and expert-designed materials: -Expedite assay development, improve robustness, and better characterize your assay -Help ensure confidence in the diagnostic result and overall laboratory test performance -Enable the development of global QC standards including proficiency materials to allow for better inter-laboratory comparisons of performance In this presentation, the speaker will discuss a case study of how a global external quality assessment (EQA) organization is using these reference materials to ensure the accuracy and consistency of one such clinical genomics application in the area of non-invasive prenatal testing (NIPT).